InvestorsHub Logo
Followers 12
Posts 1166
Boards Moderated 0
Alias Born 08/14/2014

Re: None

Thursday, 12/11/2014 8:26:40 AM

Thursday, December 11, 2014 8:26:40 AM

Post# of 18503
"Let me tell you the Davita/aethlon Houston FDAAPPROVED IDE trial could be HUGE for aemd

India Hep C trial data was great…Yes some are skeptical of India trials

Well Aemd is now enrolling for the Hep C trial in Houston per FDA IDE authorization

Who is Davita? They are a $15 BILLION dollar company with over 1 BILLION CASH in the bank & a company called Berkshire Hathaway owns about 17% of eva http://finance.yahoo.com/q?s=DVA

So if IDE Houston data is great like India……do you think it will not be of major interest to Davita…It will be of huge interest…Davita has over 1,000 dialysis centers nation wide

They are a perfect Hep C partner…….They will quickly see preliminary results.

Some consider ebola a flash in the pan…..treating Hep C patients is huge & there are tens of millions worldwide

My compass tells me this is J J's direction & current BIG INTEREST,……Effectibe Hep C treatment could mean billions of reoccurring dollars to davita & aemd

You get good Houston Hep C data and then the A F & his short buddies if still around will be toast

only mho B"
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AEMD News